Dose Finding Study of BI 836880 in Patients With Solid Tumors (Q64188295)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose Finding Study of BI 836880 in Patients With Solid Tumors |
clinical trial |
Statements
A First-in Human Phase I, Non-randomised, Open-label, Multi-center Dose Escalation Trial of BI 836880 Administered by Repeated Intravenous Infusions in Patients With Solid Tumors. (English)
0 references
5 January 2016
0 references
12 September 2018
0 references
29
0 references
18 year
0 references